Back on Top! BlueRun Ventures Wins Multiple TOP1 Awards at Zero2IPO 2022, Including Best Early-Stage Investment Firm and Best Early-Stage Investor

From December 21 to 23, Zero2IPO and PEDaily hosted China's annual venture capital summit — the 22nd China Equity Investment Annual Forum — in Shenzhen. The event brought together the country's most active investors to discuss the current state and future of equity investment. The forum also unveiled the "2022 China Equity Investment Annual Rankings."

In this year's rankings, BlueRun Ventures was named TOP1 among "2022 China's Early-Stage Investment Institutions" and received the sole award for "China's Best Early-Stage Investment Institution" of the year. This also marks BlueRun Ventures' third consecutive year in the top three of China's early-stage investment firms.

BlueRun Ventures received:

• 2022 China's Best Early-Stage Investment Institution
• 2022 China's Top 30 Early-Stage Investment Institutions — TOP1

Jui Chan, Managing Partner of BlueRun Ventures, received:

• 2022 China's Best Early-Stage Investor
• 2022 China's Top 10 Early-Stage Investors — TOP1

Founded in 2005, BlueRun Ventures has consistently pursued an early-stage technology investment strategy, focusing on Pre-A and Series A rounds across hard tech and innovative interaction, enterprise technology, consumer technology, and healthcare. It has invested in more than 150 startups, including Li Auto, Waterdrop, QingCloud, Guazi.com, Qudian, Songguo Chuxing, Ganji.com, Energy Monster, Yuntou Semiconductor, Machenike, Clouds Intelligence, AnchNet, and BioMap.

In May this year, BlueRun Ventures announced the close of a new dual-currency fund — totaling approximately RMB 5.5 billion — against market headwinds, bringing its total assets under management to over RMB 15 billion, making it one of China's largest early-stage funds.

Rooted in Silicon Valley heritage, BlueRun has always believed that "undefined" is the essence of entrepreneurship and innovation, and that early-stage investing requires pushing boundaries and daring to be first. Since 2015, BlueRun Ventures has been tracking "hard tech" investments. When hard tech projects were widely seen as incapable of generating returns, BlueRun developed its own "non-consensus" thesis: hard tech needs a soft landing, connecting underlying technological innovation with market demand.

Thank you for this recognition. Through our vision and actions, we will redefine the future of technology and life from zero to one.

Zero2IPO China Equity Investment Annual Rankings

Established in 1999, Zero2IPO is a leading integrated service platform and investment institution for entrepreneurship and venture capital in China. Since 2001, Zero2IPO Research has published the China Equity Investment Annual Rankings for 22 consecutive years, adhering to rigorous research methodologies and impartial ranking standards to provide a robust evaluation and reference framework for the industry.

Originating in Silicon Valley, BlueRun Ventures was established in 2005 as a venture capital firm focused on early-stage startups.

BlueRun Ventures currently manages multiple USD and RMB dual-currency funds in China, with assets under management exceeding RMB 15 billion, making it one of the country's largest early-stage funds. It concentrates on Pre-A and Series A rounds across hard tech and innovative interaction, enterprise technology, new consumer, and healthcare, having invested in over 150 startups including Li Auto, Waterdrop, QingCloud, Guazi.com, Qudian, Songguo Chuxing, Ganji.com, Energy Monster, Yuntou Semiconductor, Machenike, Clouds Intelligence, AnchNet, and BioMap.

BlueRun Ventures has previously been ranked first in Zero2IPO's "China's Top 30 Early-Stage Investment Institutions" and ChinaVenture's "China's Best Early-Stage Venture Capital Institutions TOP30," and was named among Preqin's Top 10 venture capital fund managers globally for sustained high-return performance.

Additionally, BlueRun Ventures has received consecutive annual honors from Forbes China, 36Kr, Cyzone, Caixin Media, CBNweekly, Jiemian, and other media organizations, including "China's Best Early-Stage Institution of the Year," "China's Top Venture Capital Institution," "Early-Stage Institution Most Welcomed by Entrepreneurs," and "Most Influential Early-Stage Institution of the Year."